Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Moore, Bryn S ^a   Mirshahi, Uyenlinh L ^a   Yost, Evan A ^a   Stepanchick, Ann N ^a   Bedrin, Michael D ^a   Styer, Amanda M ^a   Jackson, Kathryn K ^a   Still, Christopher D ^b   Breitwieser, Gerda E ^a   Gerhard, Glenn S ^a   Carey, David J ^a   Mirshahi, Tooraj ^a,b  

^a WEIS CENTER FOR RESEARCH   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOCORTIN 4 RECEPTOR; MC4R PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CELL SURFACE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; MC4R GENE; MICROSCOPY; MISSENSE MUTATION; PHENOTYPE; PROTEIN EXPRESSION; RESTING ENERGY EXPENDITURE; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; STOMACH BYPASS; WEIGHT REDUCTION; WESTERN BLOTTING; ADOLESCENT; ALLELE; BODY WEIGHT; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; OBESITY; POSTOPERATIVE PERIOD; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS AND NUMERICAL DATA; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALLELES; BODY WEIGHT; CASE-CONTROL STUDIES; FEMALE; GASTRIC BYPASS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE PERIOD; RECEPTOR, MELANOCORTIN, TYPE 4; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS; YOUNG ADULT;

EID: 84899438138     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093629     Document Type: Article

References (43)

1. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. (2003) Years of life lost due to obesity. JAMA 289: 187-193. (Pubitemid 36068706)
2. Robinson MK. (2009) Surgical treatment of obesity-weighing the facts. N Engl J Med 361: 520-521.
3. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, et al. (2003) Effect of laparoscopic roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238: 467-84; discussion 84-5.
4. Wickremesekera K, Miller G, Naotunne TD, Knowles G, Stubbs RS. (2005) Loss of insulin resistance after roux-en-Y gastric bypass surgery: A time course study. Obes Surg 15: 474-481. (Pubitemid 40605068)
5. Scott WR, Batterham RL. (2011) Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: Understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol 301: R15-27.
6. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, et al. (1997) Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46: 2119-2123. (Pubitemid 27512108)
7. Buch TR, Heling D, Damm E, Gudermann T, Breit A. (2009) Pertussis toxin-sensitive signaling of melanocortin-4 receptors in hypothalamic GT1-7 cells defines agouti-related protein as a biased agonist. J Biol Chem 284: 26411-26420.
8. Mirshahi UL, Still CD, Masker KK, Gerhard GS, Carey DJ, et al. (2011) The MC4R(I251L) allele is associated with better metabolic status and more weight loss after gastric bypass surgery. J Clin Endocrinol Metab 96: E2088-96.
9. Farooqi S, O'rahilly S. (2006) Genetics of obesity in humans. Endocr Rev 27: 710-718.
10. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, et al. (2003) Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348: 1085-1095. (Pubitemid 36337319)
11. Farooqi IS, O'rahilly S. (2005) Monogenic obesity in humans. Annu Rev Med 56: 443-458.
12. Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, et al. (2000) Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 106: 271-279. (Pubitemid 30483131)
13. Gu W, Tu Z, Kleyn PW, Kissebah A, Duprat L, et al. (1999) Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes 48: 635-639. (Pubitemid 29106881)
14. Hinney A, Hohmann S, Geller F, Vogel C, Hess C, et al. (2003) Melanocortin-4 receptor gene: Case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab 88: 4258-4267. (Pubitemid 37153729)
15. Zechner JF, Mirshahi UL, Satapati S, Berglund ED, Rossi J, et al. (2013) Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans. Gastroenterology 144: 580-590.e7.
16. Xiang Z, Proneth B, Dirain ML, Litherland SA, Haskell-Luevano C. (2010) Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist. Biochemistry 49: 4583-4600.
17. Lubrano-Berthelier C, Durand E, Dubern B, Shapiro A, Dazin P, et al. (2003) Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum Mol Genet 12: 145-153. (Pubitemid 36124450)
18. van den Berg L, van Beekum O, Heutink P, Felius BA, van de Heijning MP, et al. (2011) Melanocortin-4 receptor gene mutations in a dutch cohort of obese children. Obesity (Silver Spring) 19: 604-611.
19. Biebermann H, Krude H, Elsner A, Chubanov V, Gudermann T, et al. (2003) Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes 52: 2984-2988. (Pubitemid 37466869)
20. Tao YX. (2010) The melanocortin-4 receptor: Physiology, pharmacology, and pathophysiology. Endocr Rev. 10.1210/er.2009-0037.
21. Tao YX, Segaloff DL. (2003) Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology 144: 4544-4551.
22. Sekine-Aizawa Y, Huganir RL. (2004) Imaging of receptor trafficking by using alpha-bungarotoxin-binding-site-tagged receptors. Proc Natl Acad Sci U S A 101: 17114-17119. (Pubitemid 39627783)
23. de Felipe P, Luke GA, Hughes LE, Gani D, Halpin C, et al. (2006) E unum pluribus: Multiple proteins from a self-processing polyprotein. Trends Biotechnol 24: 68-75. (Pubitemid 43151978)
24. de Felipe P, Ryan MD. (2004) Targeting of proteins derived from self-processing polyproteins containing multiple signal sequences. Traffic 5: 616-626. (Pubitemid 39144491)
25. Nikolaev VO, Bunemann M, Hein L, Hannawacker A, Lohse MJ. (2004) Novel single chain cAMP sensors for receptor-induced signal propagation. J Biol Chem 279: 37215-37218. (Pubitemid 39195424)
26. Stutzmann F, Vatin V, Cauchi S, Morandi A, Jouret B, et al. (2007) Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: The two facets of a janus obesity gene. Hum Mol Genet 16: 1837-1844. (Pubitemid 47244532)
27. Rouskas K, Meyre D, Stutzmann F, Paletas K, Papazoglou D, et al. (2012) Loss-of-function mutations in MC4R are very rare in the greek severely obese adult population. Obesity (Silver Spring) 20: 2278-2282.
28. Wang ZQ, Tao YX. (2011) Functional studies on twenty novel naturally occurring melanocortin-4 receptor mutations. Biochim Biophys Acta 1812: 1190-1199.
29. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, et al. (2000) Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 106: 253-262. (Pubitemid 30483129)
30. Proneth B, Xiang Z, Pogozheva ID, Litherland SA, Gorbatyuk OS, et al. (2006) Molecular mechanism of the constitutive activation of the L250Q human melanocortin-4 receptor polymorphism. Chem Biol Drug Des 67: 215-229.
31. Lubrano-Berthelier C, Dubern B, Lacorte JM, Picard F, Shapiro A, et al. (2006) Melanocortin 4 receptor mutations in a large cohort of severely obese adults: Prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating. J Clin Endocrinol Metab 91: 1811-1818.
32. Stutzmann F, Tan K, Vatin V, Dina C, Jouret B, et al. (2008) Prevalence of melanocortin-4 receptor deficiency in europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes 57: 2511-2518.
33. Calton MA, Ersoy BA, Zhang S, Kane JP, Malloy MJ, et al. (2009) Association of functionally significant melanocortin-4 but not melanocortin-3 receptor mutations with severe adult obesity in a large north american case-control study. Hum Mol Genet 18: 1140-1147.
34. Branson R, Potoczna N, Kral JG, Lentes KU, Hoehe MR, et al. (2003) Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 348: 1096-1103. (Pubitemid 36337320)
35. Ahituv N, Kavaslar N, Schackwitz W, Ustaszewska A, Martin J, et al. (2007) Medical sequencing at the extremes of human body mass. Am J Hum Genet 80: 779-791. (Pubitemid 46564414)
36. Xiang Z, Litherland SA, Sorensen NB, Proneth B, Wood MS, et al. (2006) Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist. Biochemistry 45: 7277-7288. (Pubitemid 43877414)
37. Tao YX, Segaloff DL. (2005) Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects. J Clin Endocrinol Metab 90: 5632-5638.
38. Aslan IR, Campos GM, Calton MA, Evans DS, Merriman RB, et al. (2010) Weight loss after roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations. Obes Surg 7: 930-934.
39. Hatoum IJ, Stylopoulos N, Vanhoose AM, Boyd KL, Yin DP, et al. (2012) Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery. J Clin Endocrinol Metab 6: e1023-1031.
40. Valette M, Poitou C, Le Beyec J, Bouillot JL, Clement K, et al. (2012) Melanocortin-4 receptor mutations and polymorphisms do not affect weight loss after bariatric surgery. PLoS One 7: e48221.
41. Still CD, Wood GC, Chu X, Manney C, Strodel W, et al. (2013) Clinical factors associated with weight loss outcomes after roux-en-Y gastric bypass surgery. Obesity (Silver Spring). 10.1002/oby.20529; 10.1002/oby.20529.
42. Srisai D, Gillum MP, Panaro BL, Zhang XM, Kotchabhakdi N, et al. (2011) Characterization of the hyperphagic response to dietary fat in the MC4R knockout mouse. Endocrinology 152: 890-902.
43. Reinehr T, Hebebrand J, Friedel S, Toschke AM, Brumm H, et al. (2009) Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene. Obesity (Silver Spring) 17: 382-389.